the aid library

Imunidade natural contra a COVID-19 Informe científico 10 de maio de 2021

Organização Mundial da Saúde (OMS) OPAS, OMS (2021) C_WHO

Natural immunity against COVID-19 Scientific report 10 May 2021

Hipertensão e COVID-19: Informe científico - 17 de junho de 2021

Organização Mundial da Saúde (OMS) OPAS (2021) C_WHO

Hypertension and COVID-19: Scientific report - 17 June 2021

Lista de medicamentos esenciales para el manejo de pacientes que ingresan a unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID 19. Tercera versión, 1 de febrero del 2022
recommended

Organización Mundial de la Salud OMS OPS (2022) C_WHO

List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022

WHO international standard terminologies on traditional Chinese medicine

World Health Organization WHO (2022) CC

PM2.5 polluters disproportionately and systemically affect people of color in the United States

Tessum, C.; Paolella, D .A.; Chambliss, S. E.; et al. (2021) C1

Don’t pollute my future! The impact of the environment on children’s health

World Health Organization WHO (2017) C_WHO

In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau ... more

Manual Instrutivo para a assistência à gestante e puérpera frente à pandemia da covid-19

Ministerio da Saude, Brasilia (2020) CC

Instructional Manual for the care of pregnant and postpartum women in the context of the covid-19 pandemic Este Manual de Recomendações para a Assistência à Gestante e Puérpera visa orientar o acesso e a horizontalidade da assistência durante a pandemia Covid-19, abordando as vias de transmis ... more

Guia de Vigilância Epidemiológica Covid-19: Emergência de Saúde Pública de Importância Nacional pela Doença pelo Coronavírus 2019 - Atualizado em 20/01/2022

Ministerio da Saude, Brasilia (2022) CC

Covid-19 Epidemiological Surveillance Guide: Public Health Emergency of National Importance for Coronavirus Disease 2019 - version 4

Transmission modelling of environmentally persistent zoonotic diseases: a systematic review

Rees, E.M.; A. Minter, J. Edmunds et al. The Lancet (2021) CC

The Lancet Planetary Health Volume 5, ISSUE 7, e466-e478, July 01, 2021 Transmission of many infectious diseases depends on interactions between humans, animals, and the environment. Incorporating these complex processes in transmission dynamic models can help inform policy and disease control int ... more

Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review

Van Dijck C., Vlieghe E., Cox J.A. Bulletin of the World Health Organization (2018) C_WHO

Objective: To review the effectiveness of antibiotic stewardship interventions in hospitals in low- and middle-income countries.

Antimicrobial resistance in South East Asia: time to ask the right questions

Kakkar M., Chatterjee P. et. al. (2018) C2

Antimicrobial resistance (AMR) has emerged as a major public health concern, around which the international leadership has come together to form strategic partnerships and action plans. The main driving force behind the emergence of AMR is selection pressure created due to consumption of antibiotics ... more

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Green spaces and mortality: a systematic review and meta-analysis of cohort studies

Rojas-Rueda, D.; M.J. Nieuwenhuijsen, M. Gascon; et al. (2019) CC

Lancet Planet Health 2019; 3: 469–77

Heat Waves: Health Effects, Observed Trends and Climate Change

Martínez-Austria Polioptro,F and Bandala E. R (2018) CC

DOI: 10.5772/intechopen.75559 In book: Extreme WeatherPublisher: IntechOpen

Heat waves and human health

Lee, V.; F. Zermoglio; K.L.Ebi; et al. USAID (2019) C1

Emerging evidence and experience to inform risk management in a warming world

Heat Exposure and Cardiovascular Health: A Summary for Health Departments

Halaharvi, H.; Schramm, P,J.; Vaidyanathan, A.; et al. (2020) C_CDC

Extreme heat events (EHEs) are a leading cause of weather-related injury and death in the United States, and under a changing climate, these meteorological episodes are predicted to increase in both frequency and intensity. Prolonged heat exposure from EHEs places an increased strain on the heart an ... more

The Impact of Climate Change on Mental Health: A Systematic Descriptive Review

Cianconi, P.; Betrò, S.; Janiri, L. (2020) CC

BackgroundClimate change is one of the great challenges of our time. The consequences of climate change on exposed biological subjects, as well as on vulnerable societies, are a concern for the entire scientific community. Rising temperatures, heat waves, floods, tornadoes, hurricanes, droughts, fir ... more

Assessing Health Vulnerabilities and Adaptation to Climate Change

Berry, P.; P. M. Enright, J. Shumake-Guillemot et al. (2018) CC

Int. J. Environ. Res. Public Health 2018, 15(12), 2626; https://doi.org/10.3390/ijerph15122626 Climate change is increasing risks to human health and to the health systems that seek to protect the safety and well-being of populations. Health authorities require information about current associatio ... more

Using country of origin to inform targeted tuberculosis screening in asylum seekers: a modelling study of screening data in a German federal state, 2002–2015

Bozorgmehr, K.; Preussler, S.; Wagner, U. et al. (2019) CC

Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c ... more